Cătălin Crânguş, Haleon Romania country manager: The year 2025 was a challenging one, it started well. In the middle of the year we had some challenges, after the fiscal measures we saw a rather accelerated decrease in consumption, which put us in a not very good position, but in the end we managed to close the year as we hoped.
♦ Among the best-known brands under the Haleon umbrella are over-the-counter products such as Parasinus, Theraflu, pain products such as Voltaren or Panadol, vitamins under the Centrum brand, oral care products – Sensodyne, Parodontax, Corega ♦ Haleon spun off in 2022 from the British pharmaceutical giant GSK, becoming an independent company listed on the stock exchange, active in the area of consumer healthcare.
The decrease in consumption, which has affected many industries, is also felt in the local pharmaceutical market, especially in the categories of food supplements, where the VAT has more than doubled, from 9% to 21%, says Cătălin Crângu, country manager of the Haleon Romania pharma company. He believes that the second half of 2026 could see a rebound in consumption, which has contracted following fiscal recovery measures taken by the government starting in August 2025. Haleon spun off from British pharma giant GSK in 2022, becoming an independent, publicly listed company active in the consumer healthcare area. In Romania, Haleon has several product categories: in the area of pain, in respiratory health, oral health, dermatology and vitamins. Some of the best known brands are Voltaren, Parasinus, Theraflu, Sensodyne, Parodontax, Corega. «The year started quite hard, from the middle of last year we felt a setback in terms of consumption. This year, this area is even more accelerated», said Cătălin Crânguş for ZF.
For other news, analyses, articles and business information in real time, follow NV on WhatsApp Channels